Form 8-K - Current report:
SEC Accession No. 0001104659-25-064445
Filing Date
2025-07-01
Accepted
2025-07-01 08:38:37
Documents
14
Period of Report
2025-07-01
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2519396d1_8k.htm   iXBRL 8-K 46261
2 EXHIBIT 3.1 tm2519396d1_ex3-1.htm EX-3.1 7127
3 EXHIBIT 3.2 tm2519396d1_ex3-2.htm EX-3.2 99827
  Complete submission text file 0001104659-25-064445.txt   350008

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA swtx-20250701.xsd EX-101.SCH 3029
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE swtx-20250701_lab.xml EX-101.LAB 34239
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE swtx-20250701_pre.xml EX-101.PRE 22368
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2519396d1_8k_htm.xml XML 3688
Mailing Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902
Business Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902 203-883-9490
SpringWorks Therapeutics, Inc. (Filer) CIK: 0001773427 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39044 | Film No.: 251094255
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)